ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.
AstraZeneca Pharma India Limited appointed Mr. Arun Krishna as a Non-Executive Director effective August 17, 2026. Additionally, Ms. Bhavana Agrawal transitioned to a Non-Executive Director role.
Ms. Bhavana Agrawal has resigned as CFO of AstraZeneca Pharma India Ltd. Her resignation is effective August 31, 2026, to take a regional role.
AstraZeneca Pharma India appointed three new Senior Management Personnel effective Aug-Sep 2026. This strengthens leadership in Commercial, Oncology, and Rare Diseases units.
AstraZeneca Pharma India Ltd appointed Mr. Praveen K Mittal as Director – Corporate Affairs effective July 6 2026. The appointment strengthens the company’s corporate affairs and policy engagement.
AstraZeneca Pharma India Ltd announced the resignations of its Business Unit Director – Oncology and its Site Lead, Operations. The company will seek replacements to maintain continuity.
AstraZeneca Pharma India announced the resignations of senior executives Mr. Ayush Kumar Agarwal and Ms. Shikha Mirchandani Chatrath. The company is seeking suitable replacements.
AstraZeneca Pharma India appointed Ms. Shilpa Divekar Nirula as Chairperson for five years. BSR & Co. LLP was also appointed as Statutory Auditor for a 60-month term.